Versions Compared
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Purpose | ||||||
The WMDA exists to achieve the best for stem cell donors and transplant patients, the strategy has been co-created with affiliate organisations so that it will support them to harness opportunities and mitigate risks in the medium-term. The strategy aims to deliver impact in the following areas:
In 2018, WMDA was funded a EU Third Health Programme. The 2018 project includes 13 Deliverables that were submitted to and approved by the European Commission. | ||||||
Projects | ||||||
---|---|---|---|---|---|---|
2018
Any questions/comments regarding these Deliverables can be addressed to esther.pustjens@wmda.info |
The EU Health Programme | ||||
What is the Health Programme?The Health Programme is a funding instrument to support cooperation among EU countries and underpin and develop EU health activities. The legal basis for the Health Programme is agreed with the European Parliament and the Council for a period of several years. Third Health Programme (2014-2020)Regulation (EU) 282/2014 is the legal basis for the current Health Programme. With a budget of €449.4 million and throughout 23 priority areas, the Health Programme serves four specific objectives:
| ||||
---|---|---|---|---|
Space Administrator
| ||||
Helpful Links
|